Small lesions of porokeratosis show a normal proliferation rate with MIB-1

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 17, Issue 1, 2008, Pages 22-25

  Fernandez Flores, Angel ^a  

^a HOSPITAL EL BIERZO   (Spain)

Author keywords

Cutaneous basal layer; Ki 67; MIB 1; Mibelli; Porokeratosis; Proliferation rate

Indexed keywords

KI 67 ANTIGEN;

ACTINIC POROKERATOSIS; ARTICLE; CASE REPORT; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; EPIDERMIS CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; SKIN DEFECT;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; POROKERATOSIS; SKIN;

EID: 42149164956     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Otsuka F, Umebayashi Y, Watanabe SI, Kawashima M, Hamanaka S. Porokeratosis large lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility. J Cancer Res Clin Oncol. 1993;119:395-400.
2. Ackerman AB, Böer A, Bennin B, Gottlieb GJ. Definitions of terms. Histologic diagnosis of inflammatory skin diseases: An Algorithmic Method Based on Pattern Analysis [Internet]. 3rd ed. New York: Ardor Scribendi; 2005. Available from: http:/www.Derm101.com.
3. Christophers C, Braun-Falco O. Mechanisms of parakeratosis. Br J Dermatol. 1970;82:268-75.
4. Sato A, Anton-Lamprecht I, Schnyder UW. Ultrastructure of inborn errors of keratinisation: VII. Porokeratosis Mibelli and disseminated superficial actinic porokeratosis. Arch Dermatol Res. 1976;255:271-84.
5. Mann PR, Cort DF, Fairburn EA, Abdel-Aziz A. Ultrastructural studies on two cases of porokeratosis of Mibelli. Br J Dermatol. 1974;90:607-17.
6. Jaworski RC, Commens C. Ultrastructural appearances of disseminated superficial actinic porokeratosis. Ultrastruct Pathol. 1988;12:643-9.
7. Ito M, Fujiwara H, Maruyama T, Oguro K, Ishihara O, Sato Y. Morphogenesis of the cornoid lamela: histochemical, immunohistochemical, and ultrastructural study of porokeratosis. J Cutan Pathol. 1991;18:247-56.
8. Shen CS, Tabata K, Matsuki M, Goto T, Yokochi T, Yamanishi K. Premature apoptosis of keratinocytes and the dysregulation of keratinisation in porokeratosis. Br J Dermatol. 2002;147:498-502.
9. Hivnor C, Williams N, Singh F, VanVoorhees A, Dzubow L, Baldwin D, Seykora J. Gene expression profiling of porokeratosis demonstrates similarities with psoriasis. J Cutan Pathol. 2004;31:657-64.
10. Gray MH, Smoller BS, McNutt NS. Carcinogenesis in porokeratosis. Evidence for a role relating to chronic growth activation of keratinocytes. Am J Dermatopathol. 1991;13:438-44.
11. Gerdes J, Becker MH, Key G, Cattoretti G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol. 1992;168:85-6.
12. Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-63.
13. Urano Y, Sasaki S, Ninomiya Y, Oura H, Arase S. Immunohistochemical detection of p53 tumor suppresor protein in porokeratosis. J Dermatol. 1996;23:365-8.
14. Nelson C, Cowper S, Morgan M. p53, mdm-2, and p21 waf-1 in the porokeratoses. Am J Dermatopathol. 1999;21:420-5.
15. Rongioletti F, Rebora A. Disseminated porokeratosis with fatal metastatic squamous cell carcinoma: an additional case of "malignant disseminated porokeratosis." Am J Dermatopathol. 2002;24:144-8.
16. Arranz-Salas I, Sanz-Trelles A, Ojeda DB. p53 alterations in porokeratosis. J Cutan Pathol. 2003;30:455-8.
17. Kim KH, Park EJ, Seo YJ, Cho HS, Kim CW, Kim KJ, Park HR. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. J Dermatol. 2006;33:319-25.
18. Jurecka W, Neumann RA, Knobler RM. Porokeratoses: immunohistochemical, light and electron microscopic evaluation. J Am Acad Dermatol. 1991;24:96-101.
19. Shumack S, Commens C, Kossard S. Disseminated superficial actinic porokeratosis. A histological review of 61 cases with particular reference to lymphocytic inflammation. Am J Dermatopathol. 1991;13:26-31.
20. Abe M, Ishikawa O, Miyachi Y. The loss of HLA-DR antigen expression by epidermal Langerhans cell in disseminated superficial porokeratosis. Eur J Dermatol. 1997;7:303-4.
21. McNutt NS, Smoller BR. Reply by McNutt and Smoller. Am J Dermatopathol. 1992;14:61-5.
22. Otsuka F, Chi HI, Shima A, Ishibashi Y. Cytological demonstration of abnormal DNA ploidy in the epidermis of porokeratosis. Arch Dermatol Res. 1988;280:61-3.
23. Otsuka F, Shima A, Ishibashi Y. Porokeratosis has neoplastic clones in the epidermis: microfluorometric analysis of DNA content of epidermal cell nuclei. J Invest Dermatol. 1989;92:231S-3S.
24. Ninomiya Y, Urano Y, Yoshimoto K, Iwahana H, Sasaki S, Arase S, Itakura M. p53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma. J Dermatol Sci. 1997;14:173-8.
25. Özkan S, Fetil E, Aydogan T, Atabey N, Erkizan V, Pabuccuoglu U, Gunes AT. Lack of TP53 mutations in a case of porokeratosis palmaris, plantaris et disseminata. Dermatology. 2000;201:158-61.
26. Gottlieb TM, Oren M. p53 and apoptosis. Semin Cancer Biol. 1998;8:359-68.